Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

2008 ◽  
Vol 6 (6) ◽  
pp. 644-653 ◽  
Author(s):  
Laurent Peyrin–Biroulet ◽  
Pierre Deltenre ◽  
Nicolas de Suray ◽  
Julien Branche ◽  
William J. Sandborn ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Tumor Necrosis Factor ◽  
Crohn's Disease ◽  
Tumor Necrosis ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Efficacy And Safety ◽  
Tumor Necrosis Factor Antagonists ◽  
Necrosis Factor

scholarly journals Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease

2020 ◽  
Vol 18 (3) ◽  
pp. 628-636 ◽  
Author(s):  
Guillaume Bouguen ◽  
Audrey Huguet ◽  
Aurélien Amiot ◽  
Stéphanie Viennot ◽  
Franck Cholet ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Tumor Necrosis Factor ◽  
Crohn's Disease ◽  
Tumor Necrosis ◽  
Efficacy And Safety ◽  
Tumor Necrosis Factor Antagonists ◽  
Necrosis Factor

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 ◽  
Vol 117 (4) ◽  
pp. 761-769 ◽  
Author(s):  
Paul Rutgeerts ◽  
Geert D'Haens ◽  
Stephan Targan ◽  
Eric Vasiliauskas ◽  
Stephen B. Hanauer ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Tumor Necrosis Factor ◽  
Crohn's Disease ◽  
Tumor Necrosis ◽  
Efficacy And Safety ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document